Henry Schein, Inc. (NASDAQ:HSIC) Shares Purchased by Natixis

Natixis raised its holdings in Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 4.8% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 695,250 shares of the company's stock after buying an additional 31,940 shares during the period. Natixis owned about 0.56% of Henry Schein worth $48,111,000 as of its most recent SEC filing.

Other institutional investors also recently bought and sold shares of the company. Versant Capital Management Inc lifted its stake in Henry Schein by 274.6% during the fourth quarter. Versant Capital Management Inc now owns 457 shares of the company's stock worth $32,000 after purchasing an additional 335 shares during the last quarter. Venturi Wealth Management LLC boosted its holdings in shares of Henry Schein by 3,347.1% in the 4th quarter. Venturi Wealth Management LLC now owns 586 shares of the company's stock valued at $41,000 after buying an additional 569 shares in the last quarter. Quent Capital LLC grew its position in shares of Henry Schein by 91.2% in the 4th quarter. Quent Capital LLC now owns 677 shares of the company's stock valued at $47,000 after buying an additional 323 shares during the last quarter. Smartleaf Asset Management LLC raised its stake in Henry Schein by 23.2% during the 4th quarter. Smartleaf Asset Management LLC now owns 759 shares of the company's stock worth $52,000 after acquiring an additional 143 shares in the last quarter. Finally, City State Bank purchased a new stake in Henry Schein in the fourth quarter valued at $55,000. 96.62% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at Henry Schein

In other Henry Schein news, CEO Bradford C. Connett sold 4,036 shares of the business's stock in a transaction dated Wednesday, March 19th. The stock was sold at an average price of $71.15, for a total transaction of $287,161.40. Following the transaction, the chief executive officer now owns 62,688 shares in the company, valued at $4,460,251.20. The trade was a 6.05 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Philip A. Laskawy sold 2,604 shares of the stock in a transaction dated Wednesday, March 19th. The shares were sold at an average price of $71.04, for a total value of $184,988.16. Following the completion of the sale, the director now owns 24,805 shares of the company's stock, valued at approximately $1,762,147.20. This trade represents a 9.50 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 1.14% of the company's stock.

Wall Street Analysts Forecast Growth

Several brokerages have issued reports on HSIC. Jefferies Financial Group raised their price objective on Henry Schein from $77.00 to $80.00 and gave the stock a "hold" rating in a report on Thursday, January 23rd. StockNews.com downgraded Henry Schein from a "buy" rating to a "hold" rating in a research note on Thursday. Bank of America upgraded Henry Schein from an "underperform" rating to a "buy" rating and boosted their price objective for the company from $69.00 to $84.00 in a research note on Monday, January 6th. UBS Group decreased their price objective on Henry Schein from $83.00 to $80.00 and set a "neutral" rating for the company in a report on Wednesday, February 26th. Finally, Barrington Research reaffirmed an "outperform" rating and issued a $90.00 target price on shares of Henry Schein in a report on Wednesday, February 26th. Six research analysts have rated the stock with a hold rating, five have issued a buy rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat, Henry Schein currently has a consensus rating of "Moderate Buy" and an average target price of $81.10.

Henry Schein Trading Up 2.3 %

Henry Schein stock opened at $64.73 on Friday. The company has a current ratio of 1.42, a quick ratio of 0.82 and a debt-to-equity ratio of 0.46. The stock has a market cap of $7.93 billion, a PE ratio of 26.64, a P/E/G ratio of 2.13 and a beta of 0.84. The stock has a 50-day moving average price of $70.41 and a 200 day moving average price of $71.96. Henry Schein, Inc. has a 52 week low of $60.56 and a 52 week high of $82.49.

Henry Schein (NASDAQ:HSIC - Get Free Report) last released its earnings results on Tuesday, February 25th. The company reported $1.19 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.23 by ($0.04). The company had revenue of $3.19 billion during the quarter, compared to analyst estimates of $3.25 billion. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. Henry Schein's revenue was up 5.8% on a year-over-year basis. During the same period in the prior year, the business posted $0.66 earnings per share. Equities research analysts predict that Henry Schein, Inc. will post 4.74 earnings per share for the current fiscal year.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.